Capstan Therapeutics Stock

capstantx.comHealthcare / Healthcare providers & servicesFounded: 2021Funding to Date: $340MM

Capstan Therapeutics is a biotechnology company that strives to develop new treatments for a variety of diseases using in vivo cell engineering, which is a method that aims to modify cells inside the body. Their core technology involves targeted lipid nanoparticles (tLNPs) seeking to manipulate cells for therapeutic purposes. Areas of interest for the company include oncology, fibrosis, inflammatory disease, and blood disorders. Capstan Therapeutics was founded in 2021 and is headquartered in San Diego, California.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Capstan Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Capstan Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Capstan Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Capstan Therapeutics investors also invested in these private companies

Novartis Venture Fund

Team

Management Team

Justin Thacker
Chief Financial Officer
Priya Karmali Ph.D
Chief Technology Officer
Adrian Bot Ph.D
Founding Chief Scientific Officer & Executive Vice President of Research & Development
Haig Aghajanian Ph.D
Co-Founder & Vice President of Research
Laura Shawver Ph.D
President & Chief Executive Officer
Christian Homsy MD
Co-Founder
Ramin Farzaneh-Far MD
Chief Medical Officer

Board Members

Andrew Levin Ph.D
RA Capital Management
Erez Chimovits
OrbiMed
Fabio Pucci Ph.D
Leaps by Bayer
Michael Baran Ph.D
Pfizer Ventures
Michal Silverberg
Novartis Venture Fund
Nandita Shangari Ph.D
Novartis Venture Fund
Rajul Jain MD
Vida Ventures

Capstan Therapeutics stock FAQs

plusminus

Can you buy Capstan Therapeutics stock?

As Capstan Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Capstan Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy Capstan Therapeutics stock?

To invest in a private company like Capstan Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell Capstan Therapeutics stock?

Yes, you may be able to sell your Capstan Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell Capstan Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Capstan Therapeutics stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is Capstan Therapeutics a public company?

No, Capstan Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is Capstan Therapeutics’ stock price?

Capstan Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Capstan Therapeutics’ private market stock price with Forge Data.
plusminus

What is Capstan Therapeutics’ stock ticker symbol?

Capstan Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
In a funding round led by investors such as Johnson & Johnson Innovation and Forbion, Capstan Therapeutics raised $175 million.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.